Abstract
Polycythemia vera (PV) in children and adolescents is very rare. Data on clinical and laboratory evaluations as well as on treatment modalities are sparse. Here, we report the long-term clinical course of a PV patient first diagnosed more than 40 years ago at age 12. In addition, after a systematic review of the scientific medical literature, clinical and hematological data of 35 patients (19 female and 17 male) from 25 previous reports are summarized. Three patients developed PV following antecedent hematological malignancies. Budd–Chiari syndrome was diagnosed in seven patients indicating a particular risk of young patients of developing this disorder. One patient presented with ischemic stroke, one patient with gangrene, and three patients with severe hemorrhage. Three patients died from disease-related complications. Hematocrit levels and platelet counts were not correlated with disease severity. Leukocytosis >15 × 109/L was present in 9/35 patients and associated with a thromboembolic or hemorrhagic complication in seven patients. The few available data on molecular genetics and endogenous erythroid colony growth indicate changes comparable to those detectable in adult patients. Treatment varied enormously. It included aspirin, phlebotomy, hydroxycarbamide, busulfan, melphalan, pyrimethamine, and interferon-alpha. Two patients successfully underwent stem cell transplantation. Currently, it is impossible to treat an individual pediatric PV patient with an evidence-based regimen.
Similar content being viewed by others
References
Osgood EE (1965) Polycythemia vera: age relationship and survival. Blood 26:243–256
Wick H (1969) Polycythaemia vera mit neurologischen Komplikationen bei einem 12jährigen Kind. Schweiz Med Wochenschr 99:186–189
Park MJ, Shimada A, Asada H, Koike K, Tsuchida M, Hayashi Y (2006) JAK2 mutation in a boy with polycythemia vera, but not in other pediatric hematologic disorders. Leukemia 20:1453–1454. doi:10.1038/sj.leu.2404259
Aggeler PM, Pollycove M, Hoag S, Donald WG, Lawrence JH (1961) Polycythemia vera in childhood. Studies of iron kinetics with Fe59 and blood clotting factors. Blood 17:345–350
Berbis P, Devaux J, Benveniste MJ, Perrimond H, Privat Y (1987) Severe erosive lichen planus and polycythemia vera in an adolescent. Dermatologica 174:244–248
Cap J (1961) Polycythemia vera in an 11-year-old child. Bone marrow depression after daraprim treatment. Cesk Pediatr 16:49–53
Cobo F, Cervantes F, Garcia-Pagan JC, Bosch J, Rozman C, Montserrat E (1996) Budd-Chiari syndrome associated with chronic myeloproliferative syndromes: analysis of 6 cases. Med Clin (Barc) 107:660–663
Crosato M, Castello D (1964) Vaquez’s disease in childhood. Case report. Panminerva Med 105:62–68
Danish EH, Rasch CA, Harris JW (1980) Polycythemia vera in childhood: case report and review of the literature. Am J Hematol 9:421–428
Esposito L, Ferrara M (1976) Polycythemia vera in childhood. Data on platelet function and blood coagulation factors. Pediatria (Napoli) 84:208–223
Hann HW, Festa RS, Rosenstock JG, Cifuentes E (1979) Polycythemia vera in a child with acute lymphocytic leukemia. Cancer 43:1862–1865. doi:10.1002/1097-0142(197905)43:5<1862::AID-CNCR2820430540>3.0.CO;2-K
Heilmann E, Klein CE, Beck JD (1983) Primary polycythaemia in childhood and adolescence. Folia Haematol Int Mag Klin Morphol Blutforsch 110:935–941
Marlow AA, Fairbanks VF (1960) Polycythemia vera in an eleven-yr-old girl. N Engl J Med 263:950–952
Melear JM, Goldstein RM, Levy MF et al (2002) Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation 74:1090–1095. doi:10.1097/00007890-200210270-00006
Nagy K, Hunyadi K, Feher I et al (1996) Polycythemia vera in an 11-year old girl. Orv Hetil 137:27–30
Natelson EA, Lynch EC, Britton HA, Alfrey CP (1971) Polycythemia vera in childhood. A case with chromosomal abnormality, immunoglobulin deficiency, and chronic consumption coagulopathy. Am J Dis Child 122:241–244
Olpinski M, Jakiela T, Korczowski R (1996) Interferon alpha in the treatment of polycythemia vera in a 13-year old girl. Pediatr Pol 71:705–707
Poggi V, Migliorati R, Fiore M, Amoroso R, Ghio R, Fiorillo A (1984) Polycythemia vera: a new case report with onset in infancy. Haematologica 69:458–463
Roth M, Haag K, Krause T, Blum U, Hellerich U (1990) Aszites und Splenomegalie im Kindesalter. Med Klin 85:529–532
Stobart K, Rogers PC (1994) Allogeneic bone marrow transplantation for an adolescent with polycythemia vera. Bone Marrow Transplant 13:337–339
Sutherland ND, Gonzalez-Peralta R, Douglas-Nikitin V, Hunger SP (2004) Polycythemia vera in a child following treatment for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 26:315–319. doi:10.1097/00043426-200405000-00012
Turker M, Ozer EA, Oniz H, Atabay B, Yaprak I (2002) Polycythemia vera in a 12-year-old girl: a case report. Pediatr Hematol Oncol 19:263–266. doi:10.1080/08880010252899433
Vodoff MV, Nelken B, Vic P, Farriaux JP (1996) Treatment with hydroxyurea of polycythemia vera in a 11 year old girl. Arch Pediatr 3:870–873. doi:10.1016/0929-693X(96)87575-0
Kovalev Iu R, Erman LV (1977) Polycythemia vera in children. Probl Gematol Pereliv Krovi 22:52–55
Cario H, Schwarz K, Herter JM et al (2008) Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera. Br J Haematol 142:622–626. doi:10.1111/j.1365-2141.2008.07220.x
Kelly K, McMahon C, Langabeer S, Eliwan H, O’Marcaigh A, Smith OP (2008) Congenital JAK2V617F polycythemia vera: where does the genotype-phenotype diversity end? Blood 112:4356–4357. doi:10.1182/blood-2008-08-175620
Teofili L, Giona F, Martini M et al (2007) Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. J Clin Oncol 25:1048–1053. doi:10.1200/JCO.2006.08.6884
Teofili L, Giona F, Martini M et al (2007) The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia. Blood 110:3384–3386. doi:10.1182/blood-2007-06-094276
Cario H, Pahl HL, Schwarz K et al (2003) Familial polycythemia vera with Budd-Chiari syndrome in childhood. Br J Haematol 123:346–352. doi:10.1046/j.1365-2141.2003.04591.x
Najean Y, Mugnier P, Dresch C, Rain JD (1987) Polycythaemia vera in young people: an analysis of 58 cases diagnosed before 40 years. Br J Haematol 67:285–291. doi:10.1111/j.1365-2141.1987.tb02349.x
Perea G, Remacha A, Besses C, Jimenez M, Florensa L, Cervantes F (2001) Is polycythemia vera a serious disease in young adults? Haematologica 86:543–544
De Stefano V, Teofili L, Leone G, Michiels JJ (1997) Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 13:411–418. doi:10.1055/s-2007-996117
Barbui T, Carobbio A, Rambaldi A, Finazzi G (2009) Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor? Blood . doi:10.1182/blood-2009-02-206797
Landolfi R, Di Gennaro L, Barbui T et al (2007) Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera. Blood 109:2446–2452. doi:10.1182/blood-2006-08-042515
Caramazza D, Caracciolo C, Barone R et al (2009) Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms. Ann Hematol . doi:10.1007/s00277-009-0706-x
Lippert E, Boissinot M, Kralovics R et al (2006) The JAK2–V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera. Blood 108:1865–1867. doi:10.1182/blood-2006-01-013540
Tefferi A, Thiele J, Orazi A et al (2007) Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 110:1092–1097. doi:10.1182/blood-2007-04-083501
Reinhard H, Klingebiel T, Lang P, Bader P, Niethammer D, Graf N (2008) Stem cell transplantation for polycythemia vera. Pediatr Blood Cancer 50:124–126. doi:10.1002/pbc.20906
Cottrill C, Geller A, diSpaltro FX, Weissglass B, Klainer AS, Bisaccia E (1994) Control of polycythaemia vera with photochemotherapy in a patient with cutaneous T-cell lymphoma. Br J Haematol 86:225–226. doi:10.1111/j.1365-2141.1994.tb03286.x
Heinle EW Jr, Sarasti HO, Garcia D, Kenny JJ, Westerman MP (1966) Polycythemia vera associated with lymphomatous diseases and myeloma. Arch Intern Med 118:351–355. doi:10.1001/archinte.118.4.351
Khojasteh A, Perry MC (1981) Coexistence of diffuse lymphocytic lymphoma and polycythemia vera. South Med J 74:771–772
Rizzi R, Liso A, Pannunzio A, Carluccio P, Specchia G, Liso V (2002) Concomitant primary polycythemia vera and follicle center cell non-Hodgkin lymphoma: a case report and review of the literature. Leuk Lymphoma 43:2217–2220. doi:10.1080/1042819021000016113
Stolinsky DC (1981) Twelve-year remission of polycythemia vera following Hodgkin’s disease and chemotherapy. CA Cancer J Clin 31:57–60. doi:10.3322/canjclin.31.1.57
Bosch F, Cervantes F, Lopez-Guillermo A, Carreras E, Montserrat E, Rozman C (1992) Polycythaemia vera following non-Hodgkin’s lymphoma. Leuk Lymphoma 8:501–502. doi:10.3109/10428199209051034
Harrison P, Neilson JR, Lumley MA, Milligan DW (1996) Development of polycythaemia rubra vera following treatment for centroblastic lymphoma. Acta Haematol 96:113–114. doi:10.1159/000203729
Chabannon C, Bost M, Hollard D (1994) A case of polycythemia vera occurring in a patient with acute non-lymphoblastic leukemia (ANLL) in long-term first complete remission. Leukemia 8:1243–1244
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cario, H., McMullin, M.F. & Pahl, H.L. Clinical and hematological presentation of children and adolescents with polycythemia vera. Ann Hematol 88, 713–719 (2009). https://doi.org/10.1007/s00277-009-0758-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-009-0758-y